CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine plus sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results

DSpace Repository

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine plus sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results

Author: Sinn, M.; Liersch, T.; Riess, H.; Gellert, K.; Stuebs, P.; Waldschmidt, D.; Lammert, F.; Maschmeyer, G.; Bechstein, W.; Bitzer, M.; Denzlinger, C.; Hofheinz, R.; Lindig, U.; Ghadimi, M.; Hinke, A.; Striefler, J. K.; Pelzer, U.; Bischoff, S.; Bahra, M.; Oettle, H.
Tübinger Autor(en):
Bitzer, Michael
Published in: European Journal of Cancer (2020), Bd. 138, S. 172-181
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2020.06.032
ISSN: 1879-0852
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)